To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m
Oaktree Capital Management will provide $175 million in debt financing for this deal.
